In general, the use of insulin is associated with increased mortality due to COVID-19 (OR=2.10 95% CI, 1.51-2.93); high heterogeneity was observed (I2 statistic=71.5%, p<0.001) (Figure 2). This evidence concerns the gene INS and COVID-19.